DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174471

Malignant placental trophoblastic tumour a diagnostic dilemma: rare association with focal segmental glomerulonephritis and cardiomyopathy

Molina U. Patel, Chetna S. Vyas, Smruti B. Vaishnav

Abstract


Placental site trophoblastic tumour (PSTT) is the rarest form of Gestational trophoblastic neoplasia (GTN).It has a wide clinical spectrum of presentation and its complications have a multi organ involvment. Inspite of the advances in HCG assays and sensitive unltrasounds, its diagnosis and course in every case is a mystery. However, it is only rarely associated with glomerulonephritis. Most cases have not been biopsied and the specific nature of renal involvement is not clearly understood. Here we report a case of PSTT with glomerulonephritis and cardiomyopathy.


Keywords


Placental site trophoblastic tumor, Glomerulonephritis (GN), Gestational trophoblastic neoplasia, Trophoblastic neoplasia

Full Text:

PDF

References


Cole ME, Broaddus R, Thaker P, Landen C, Freedman RS. Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis. Nature Reviews. Clin Oncol. 2008;5(3):171.

Piura B. Placental site trophoblastic tumor e a challenging rare entity. Eur J Gynecol Oncol. 2006;27(6):545-551.

Xiao C, Zhao J, Li M, Zhao D, Xiang Y. Lupus nephritis associated with placental site trophoblastic tumor: A case report and review of the literature. Gynecol Oncol Case Rep. 2014;9:26-28.

Huang F, Zheng W, Liang Q, Yin TDiagnosis and treatment of placental site trophoblastic tumor. Int J Clin Exp Pathol. 2013;6(7):1448-51.

Lan C, Li Y, He J, Liu J. Placental site trophoblastic tumor: lymphatic spread and possible target markers. Gynecol Oncol. 2010;116(3):430-7.

Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001;82:415-9.

Hui P, Parkash V, Perkins AS, Carcangiu ML. Patho- genesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Invest. 2000;80(6):965-972.

Muller-Hocker J, Obernitz N, Johannes A, Lohrs U. p53 gene product and EGF receptors are highly expressed in placental site trophoblastic tumor. Hum Pathol. 1993;28(11):1302-6.

Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 2006;100:511-520.

Agarwal N, Parul Kriplani A, Vijayaraghavan M. Placental site trophoblastic tumour. J Postgrad Med. 2002;48(3):211.

Mazzucco G, Colla L, Monga G. Kidney involvement in a patient affected by placental site trophoblastic tumor. Am J Kidney Dis. 2011;57:516-520.

Yang JW, Choi SO, Kim BR. Nephrotic syndrome associated with invasive mole: a case report. Nephrol. Dial. Transplant. 2010;25:2023-6.

Batra V, Kalra OP, Mathur P. Membranous glomerulopathy associated with placental site trophoblastic tumour: a case report. Nephrol Dial Transplant. 2007;22:1766-8.

Altiparmak MR, Pamuk ON, Pamuk GE. Membranous glomerulonephritis in a patient with choriocarcinoma: case report. South Med J. 2003;96:198-200.

Komatsuda A, Nakamoto YK. A Case report: nephrotic syndrome associated with a total hydatidiform mole. Am J Med Sci. 1992;303:309-312.

Young RH, Scully RE, McCluskey RT. A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. Hum Pathol. 1985;16:35-42.